Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06461039
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-11
Brief Title:
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Investigation of the Effect of NNC0487-0111 on Pharmacokinetics of an Oral Combination Contraceptive Ethinylestradiol and Levonorgestrel and Gastric Emptying in Females of Non-childbearing Potential
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study medicine NNC0487-0111 to improve the treatment options for people living with overweight and obesity or with type 2 diabetes The purpose of the study is to investigate if NNC0487-0111 affects how effective birth control pills are Participants will take 1-tablet once daily The study medicine will taken orally for 18 weeks and then study medicine will be injected with a thin needle in a skin fold in the abdomen for 9 weeksThe study will last for about 35 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1300-3685 | OTHER | World Health Organization WHO | None |